Peripheral ganglioneuroblastoma

Summary

Peripheral ganglioneuroblastoma (MONDO:0003327) is a disease. A subtype of peripheral nervous system neoplasm — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	peripheral ganglioneuroblastoma
Mondo ID	MONDO:0003327
DOID	DOID:5195
NCIT	C6594
UMLS	C1335387
MedGen	233850
GARD	0023451
Anatomy (UBERON)	UBERON:0000010
Is cancer (heuristic)	no

Also known as: ganglioneuroblastoma (disease) of peripheral nervous system · peripheral ganglioneuroblastoma · peripheral nervous system ganglioneuroblastoma · peripheral nervous system ganglioneuroblastoma (disease) · PNS ganglioneuroblastoma

Disease family

This is a subtype of peripheral nervous system neoplasm. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › nervous system disorder › peripheral nervous system disorder › peripheral nervous system neoplasm › peripheral ganglioneuroblastoma

Related subtypes (8): autonomic nervous system neoplasm, nerve sheath neoplasm, cranial nerve neoplasm, mediastinal neural neoplasm, nerve plexus neoplasm, nerve root neoplasm, peripheral nervous system cancer, benign neoplasm of peripheral nervous system

Subtypes (2): mediastinum ganglioneuroblastoma, adrenal gland ganglioneuroblastoma

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.